PharmaSeq, Hybridon | GenomeWeb

PharmaSeq, Hybridon


PharmaSeq, of Monmouth Junction, NJ, has received US Patent Number 6,376,187, “Electronically-indexed solid-phase assay for biomolecules.” This patent covers methods and materials for detecting biomolecules using beads with attached microtransponders that have information relevant to the assay encoded in their memory elements. The patent also describes a device that encodes the information in the transponders and reads the information. A similar patent, Number 6,361,950, was issued March 23rd.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.